Mesenchymal stem cell therapy in type 2 diabetes mellitus

@inproceedings{Zang2017MesenchymalSC,
  title={Mesenchymal stem cell therapy in type 2 diabetes mellitus},
  author={Li Wei Zang and Haojie Hao and Jiejie Liu and Yijun Li and Weidong Han and Yiming Mu},
  booktitle={Diabetology & metabolic syndrome},
  year={2017}
}
Type 2 diabetes mellitus (T2DM), which is characterized by the combination of relative insulin deficiency and insulin resistance, cannot be reversed with existing therapeutic strategies. Transplantation of insulin-producing cells (IPCs) was once thought to be the most promising strategy for treating diabetes, but the pace from the laboratory to clinical application has been obstructed due to its drawbacks. Mesenchymal stem cells (MSCs) harbor differentiation potential, immunosuppressive… CONTINUE READING
BETA
3
Twitter Mentions

Similar Papers

Figures and Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 12 CITATIONS

Targeted induction of bone marrow mesenchymal stem cells to have effectiveness on diabetic pancreatic restoration

  • In Vitro Cellular & Developmental Biology - Animal
  • 2019
VIEW 2 EXCERPTS
CITES BACKGROUND

Current Status of Stem Cell Treatment for Type I Diabetes Mellitus

  • Tissue Engineering and Regenerative Medicine
  • 2018
VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 87 REFERENCES

Efficacy of autologous bone marrow-derived mesenchymal stem cell and mononuclear cell transplantation in type 2 diabetes mellitus: a randomized, placebocontrolled comparative study

SDP Bhansali, V Kumar, MK Yadav, A Jain, S Mudaliar
  • Stem Cells Dev
  • 2017

Clinical efficacy of stem cell therapy for diabetes mellitus: a meta-analysis

A El-Badawy, El-Badri N. E-BN
  • PLoS ONE
  • 2016
VIEW 1 EXCERPT

Long term effect and safety of Wharton’s jelly-derived mesenchymal stem cells on type 2 diabetes

JWY Hu, H Gong, +4 authors H. Xu
  • Exp Ther Med
  • 2016